Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. News
  7. Press Releases
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
Delayed Bolsas y Mercados Espanoles  -  11:38 2022-10-04 am EDT
9.000 EUR   +0.25%
10/03Grifols appoints executive chairman as seeks to speed recovery
RE
10/03Grifols Announces Management Changes
CI
10/03Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GRIFOLS, S.A.
10/03Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity ..
AQ
09/26Grifols' Board of Directors communication in the context of considerable geopolitical u..
AQ
09/21Ontario Health Coalition - Health Coalitions denounce for-profit deal by Canadian Blood..
AQ
09/21Grifols S A : United States District Court Issues Preliminary Injunction against Plasma Ba..
PU
09/15GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Anti..
AQ
09/07Grifols S A : September 7 2022Grifols enters into agreement with Canadian Blood Services t..
PU
09/07Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficien..
AQ
07/281H 2022 Consolidated interim financial statements
AQ
07/281H2022 Earnings results
AQ
07/28Grifols sold MedKeeper to affiliates of the US company Becton Dickinson for US$ 93 mill..
AQ
07/11Grifols S A : awarded prestigious LEED Gold certification for new building at HQ complex
PU
06/30Grifols 2022 Investor and Analyst Meeting
AQ
06/10Grifols S A : highlights an increase in plasma and underscores innovation and sustainabili..
PU
06/10Grifols S A : June 10 2022Grifols highlights an increase in plasma and underscores innovat..
PU
06/10Information on the resolutions approved at the AGM on June 10, 2022
AQ
05/19GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform..
AQ
05/06Notice of Ordinary General Shareholders' Meeting
AQ
04/29Grifols restates the consolidated annual accounts of the fiscal year 2021 - OIR
AQ
04/29Grifols restates the consolidated annual accounts of the fiscal year 2021 - FS
AQ
04/25Grifols Completes The Acquisition Of : a strategic and transformational transaction to acc..
PU
04/25April 25 2022grifols Completes The A : a strategic and transformational transaction to acc..
PU
04/25Grifols completes the acquisition of Biotest
AQ
04/12Grifols obtains all regulatory approvals to close the Biotest acquisition
AQ
03/17Grifols S A : Transcript video (english)
PU
03/15Grifols S A : Araclon Biotech advances in its innovative vaccine and diagnostic test for A..
PU
03/14Grifols' XEMBIFY® receives European approvals, expanding access to innovative therapie..
AQ
03/11Grifols' XEMBIFY® receives European approvals, expanding access to innovativ..
AQ
02/28FY21 Earning results release - FS
AQ
02/28FY21 Earning results release - PR&Presentation
AQ
02/28Audit Committee and Sustainability Committee reorganization, as well as the appointment..
AQ
02/28Grifols S A : 2021 second half earnings release
PU
02/28Grifols S A : demonstrates resilient performance despite a challenging backdrop while reco..
PU
02/28Grifols S A : February 28, 2022Grifols demonstrates resilient performance despite a challe..
PU
02/25Grifols S A : Group annual consolidated accounts, auditor's report and directors' report f..
PU
02/24Grifols signs global collaboration agreement with Endpoint Health to develop and commer..
AQ
01/26Grifols S A : maintains its standing in the Bloomberg Gender-Equality Index for its commit..
PU
01/26Grifols S A : January 26, 2022Grifols maintains its standing in the Bloomberg Gender-Equal..
PU
01/26Grifols S A : achieves a high level of acceptance of its PTO to Biotest and advances on it..
PU
01/26Grifols S A : January 26, 2022Grifols achieves a high level of acceptance of its PTO to Bi..
PU
01/18Grifols S A : Egypt begins taking plasma donations
PU
01/11Grifols S A : announces the expiration of the Asset sale Offer
PU
01/11Tender Offer - Results Announcement
AQ
2021Grifols S A : moves forward with its divestment plan by agreeing to sell VCN Biosciences
PU
2021Grifols S A : December 14, 2021Grifols moves forward with its divestment plan by agreeing ..
PU
2021Grifols S A : announces the commencement of an Asset sale Offer
PU
2021Grifols S A : receives first certifications for new In Vitro Diagnostics Medical Devices E..
PU
2021Asset Sale Offer - Launch Announcement
AQ
2021Grifols S A : lanza un nuevo servicio de tratamiento a domicilio para pacientes con défici..
PU
2021Grifols S A : launches new home-care treatment service for patients with alpha-1 antitryps..
PU
2021Grifols S A : and GIC obtain authorization for their strategic agreement for USD 1 billion
PU
2021Grifols S A : November 17, 2021Grifols and GIC obtain authorization for their strategic ag..
PU
2021Grifols S A : is included on the Dow Jones Sustainability World Index
PU
2021Grifols S A : November 15, 2021Grifols is included on the Dow Jones Sustainability World I..
PU
2021Grifols advances on the execution of its strategic plan
PU
2021November 11, 2021Grifols advances on the execution of its strategic plan
PU
2021Grifols introduces ALBUTEIN FlexBag(TM) (Albumin U.S.P.) in 5% and 25% concentrations,..
AQ
2021Grifols S A : earns approval for the voluntary public tender offer of Biotest and advances..
PU
2021Grifols S A : October 26, 2021Grifols earns approval for the voluntary public tender offer..
PU
2021Grifols S A : and Egypt inaugurate first African plasma-supply platform, in Cairo, as part..
PU
2021Grifols S A : increases access to plasma-derived therapies as part of its commitment to do..
PU
2021Grifols S A : October 13, 2021Grifols increases access to plasma-derived therapies as part..
PU
2021Grifols S A : divests its hemostasis technology business for USD 25 million
PU
2021Grifols S A : October 6, 2021Grifols divests its hemostasis technology business for USD 25..
PU
2021Grifols S A : closes its EUR 2 billion bond issuance to finance its investment in Biotest
PU
2021Grifols S A : October 5, 2021Grifols closes its EUR 2 billion bond issuance to finance its..
PU
2021Grifols S A : Form 6-K)
PU
2021Grifols S A : begins commercializing TAVLESSE® in France, Italy and Spain to tr..
AQ
2021Grifols S A : earns its first Fitch corporate rating with a BB- and stable outlook
AQ
2021Grifols S A : begins commercializing TAVLESSE® in France, Italy and Spain to treat chronic..
PU
2021Grifols S A : Form 6-K)
PU
2021Grifols S A : announces its investment in Biotest
PU
2021Grifols S A : September 17, 2021Grifols announces its investment in Biotest
PU
2021Grifols S A : Form 6-K)
PU
2021Grifols S A : August 16, 2021Grifols advances on its strategic investment from GIC with 90..
PU
2021Grifols : Q2 Earnings Snapshot
AQ
1  2  3  4Next
Upcoming event on GRIFOLS, S.A.